P2X7R-mediated NLRP3 activation involved in IL-1β production by hepatic stellate cells may be associated with extracellular matrix deposition, suggesting that blocking the P2X7R-NLRP3 axis may be a potential therapeutic target for liver fibrosis (74). The gene discussed is NLRP3; the disease is Hepatic fibrosis.